Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
12/2008
12/11/2008US20080305996 Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same
12/11/2008US20080305189 Treatment of aspirin resistance with radix salviae miltiorrhizae, its extract and composition
12/11/2008US20080305172 Ophthalmic depot formulations for periocular or suconjunctival administration
12/11/2008US20080305167 Tamper-resistant oral opioid agonist formulations
12/11/2008US20080305110 Novel Ligand of G Protein Coupled Receptor Protein and Use Thereof
12/11/2008CA2726848A1 Hydroxyproline compositions and uses thereof
12/11/2008CA2691039A1 Il-18 and protein kinase r inhibition for the treatment of copd
12/11/2008CA2689518A1 A novel bone mass increasing agent
12/11/2008CA2689242A1 Agent and method for treatment of cancer
12/11/2008CA2600147A1 Combination for treatment of diabetes mellitus
12/10/2008EP2000149A1 Chimeric anti-CD20 antibody
12/10/2008EP2000136A2 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors
12/10/2008EP1998796A2 Gdf-9/bmp-15 modulators for the treatment of bone disorders
12/10/2008EP1998778A1 Use of (s)-roscovitine for manufacturing a medicine
12/10/2008EP1998765A2 Pharmaceutical combinations of hcv-protease and -ires inhibitors
12/10/2008EP1998764A2 Methods for treating cognitive and other disorders
12/10/2008EP1998759A2 Combinations of hcv protease inhibitor(s) and cyp3a4 inhibitor(s), and methods of treatment related thereto
12/10/2008EP1677827B1 Combinations for hcv treatment
12/10/2008EP1663185B1 Prevention and treatment of inflammation-induced and/or immune-mediated bone loss
12/10/2008EP1274450B1 Medical uses of agonsist and antagonists of IL-174
12/10/2008EP1249160B1 Model animal with favorite onset of rheumatoid arthritis
12/10/2008EP1220915B1 Splice variant of head trauma induced cytoplasmatic calcium binding protein
12/10/2008EP1042350B1 Inducible phosphofructokinase and the warburg effect
12/10/2008CN101321745A Nitrogen-containing heterocyclic compound and pharmaceutical application thereof
12/10/2008CN101321539A Novel combination of anticholinergics, ss2-adrenoceptor agonists, antileukotrienes (leukotriene receptor antagonists), glucocorticoids and/or PDE 4 inhibitors for the treatment of inflammatory disease
12/10/2008CN101318020A Anti-anxiety or/and dumps medicament composition and uses thereof
12/10/2008CN101318019A Compositions and methods for the therapy of inflammatory bowel disease
12/10/2008CN101317821A Ultra-fine dry powder particle suitable for drug administration for lung, and preparation method thereof
12/10/2008CN100441594C Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction
12/10/2008CN100441240C Bone grafting material, comprising a porous carrier and at least one pyrrolindone, a method for its production and an implant
12/10/2008CN100441224C Solid dosage form comprising caffeine
12/10/2008CN100441221C Method of reducing side effects of chemotherapy in cancer patient
12/10/2008CN100441220C Composition containing dipeptide of histidine and alanine for reducing uric acid
12/10/2008CN100441176C Methods and compositions to determine the chemosensitizing dose of suramin used in combination therapy
12/10/2008CN100441175C Use of compounds for the prevention of drug-induced cell toxicity
12/10/2008CN100441156C Intrauterine device of composite material
12/09/2008US7462642 Anti-cancer combinations
12/09/2008US7462465 Nucleic acid encoding KCNB potassium channel
12/09/2008US7462368 Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino]butanoate
12/09/2008US7462358 Antigenic polypeptide SE36 of malaria plasmodium, process for purification thereof, and vaccine and diagnostic agent using the antigen
12/09/2008CA2415447C Novel .gamma. crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same
12/09/2008CA2389650C Composition for treatment of constipation and irritable bowel syndrome
12/09/2008CA2323805C Analgesic combination comprising nmda receptor antagonists and narcotic analgesics
12/09/2008CA2286913C Composition and methods using an eutomer
12/04/2008WO2008147807A2 Cholesterol-interacting layered phyllosilicates and methods of reducing hypercholesteremia in a mammal
12/04/2008WO2008147057A1 Composition for treating ischemic limb disease comprising stem cells derived from adipose tissue
12/04/2008WO2008146911A1 Antibody directed against il13ra2, and diagnostic/therapeutic agent comprising the antibody
12/04/2008WO2008145697A1 Cancer treatment combination therapy comprising vinflunine and trastuzumab
12/04/2008WO2008145281A2 Formulations containing triazinones and iron
12/04/2008WO2008144888A1 Formulations for the oral administration of therapeutic agents and related methods
12/04/2008WO2008127710A3 Methods for treating cancer resistant to erbb therapeutics
12/04/2008WO2008109034A3 Modulating pdx-1 with pcif1, methods and uses thereof
12/04/2008WO2008103392A3 Modulation of nkt cell activity with antigen-loaded cdid molecules
12/04/2008WO2008099144A3 Tgf-beta stimulant and further agent to reduce side effects
12/04/2008WO2008079728A3 Alpha-2b adrenergic receptor agonist and serotonin-norepinephrine reuptake inhibitor compositions for treating chronic pain
12/04/2008WO2008073942A3 Pharmaceutical compositions and their methods of use
12/04/2008WO2008055801A3 Antidiabetogenic calcium-peptide composition
12/04/2008WO2007095497A3 Compositions and methods for prevention and treatment of cachexia
12/04/2008US20080300384 T-bet compositions and methods of use thereof
12/04/2008US20080300249 tyrosine kinase inhibitors such as 5-(3,3-Dimethyl-ureido)-3-heptyloxy-isothiazole-4-carboxylic acid amide, used for treating hyperproliferative disorders in mammals; anticarcinogenic agents; antiproliferative agents
12/04/2008US20080300238 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
12/04/2008US20080300226 Combination of Anticholinergics and Glucocorticoids for the Long-Term Treatment of Asthma and COPD
12/04/2008US20080300224 Treatment of conditions relating to hormone deficiencies by administration of progestins
12/04/2008US20080300220 Linkable Lewis X Analogs
12/04/2008US20080300219 Novel interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis
12/04/2008US20080299596 Substrates and assays for beta-secretase activity
12/04/2008US20080299547 Novel stra6 polypeptides
12/04/2008US20080299536 Material and Methods for Nerve Grafting
12/04/2008US20080299214 Intervertebral Disc Repair, Methods and Devices Therefor
12/04/2008US20080299120 Multivalent antibodies and uses therefor
12/04/2008US20080299119 Polypeptides homologous to vegf and bmp1
12/04/2008US20080299116 Vascular Endothelial Cell Growth Factor Antagonists and Uses Thereof
12/04/2008US20080299102 Novel BACE proteins, nucleic acid molecules therefor, novel crystal structure of novel BACE proteins, and methods for making and using
12/04/2008DE202005021598U1 Dermatologische Formulierung Dermatological formulation
12/04/2008CA2688613A1 Formulations containing triazinones and iron
12/04/2008CA2688111A1 Cholesterol-interacting layered phyllosilicates and methods of reducing hypercholesteremia in a mammal
12/04/2008CA2688036A1 Formulations for the oral administration of therapeutic agents and related methods
12/03/2008EP1997534A1 Cancer treatment combination therapy comprising vinflunine and trastuzumab
12/03/2008EP1997513A1 Photodynamic therapy for treating conditions of the eye
12/03/2008EP1997512A2 Methods for treating TWEAK-related conditions
12/03/2008EP1997506A1 Use of ck2 inhibitor for the treatment and chemosensibilization of refractory tumors to anticancer drugs
12/03/2008EP1997498A2 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport
12/03/2008EP1997486A1 Therapeutic agent for functional brain disease
12/03/2008EP1996233A2 Combinations comprising a histone deacetylase inhibiting agent and a nuclear hormone receptor ligand for treating cardiovascular conditions
12/03/2008EP1996232A2 CANCER TREATMENT COMBINING LYMPHODEPLETING AGENT WITH CTLs AND CYTOKINES
12/03/2008EP1996213A2 Method and compositions for potentiating pharmaceuticals with amino acid based medical foods
12/03/2008EP1996193A2 Combined treatment with an egfr kinase inhibitor and an agent that sensitizes tumor cells to the effects of egfr kinase inhibitors
12/03/2008EP1996014A1 Composition for treating bacterial, viral, fungal diseases, inflammation and pain
12/03/2008EP1651061B1 Supplement preparation containing cartilage and silver
12/03/2008EP1541554B1 Crystal for oral solid drug and oral solid drug for dysuria treatment containing the same
12/03/2008EP1538980A4 Devices and methodologies useful in body aesthetics
12/03/2008EP1478366B1 Pharmaceutical combinations of meloxicam, codeine phosphate and paracetamol
12/03/2008EP1423105B1 Combinations of dmxaa and other anti-cancer agents
12/03/2008EP1390045B1 The use of a compound with a negatively charged domain of phosphorous-containing radicals for the treatment of restenosis
12/03/2008EP1313462B1 Use of asiatic acid or asiaticoside for treatment of cancer
12/03/2008EP1305330B1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivatives as anti-inflammatory agents
12/03/2008EP1303293B1 Sequential administration of cpt-11 and apo-2l polypeptide
12/03/2008EP1187632B1 TREATMENT WITH ANTI-ErbB2 ANTIBODIES
12/03/2008EP1121140B1 Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease
12/03/2008EP0812208B1 Pharmaceutical compositions for controlled release of soluble receptors
1 ... 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 ... 1151